Mark Heise Selected Research

Mark Heise Research Topics

6	Infections 01/2021 - 04/2010
4	Virus Diseases (Viral Diseases) 01/2018 - 10/2010
2	Neoplasms (Cancer) 01/2021 - 07/2015
2	COVID-19 01/2021 - 01/2021
2	Eosinophilia 03/2014 - 12/2011
1	Acute Coronary Syndrome 03/2022
1	Peripheral Arterial Disease 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Myocardial Infarction 01/2021
1	Bites and Stings (Sting) 01/2018
1	Alphavirus Infections 01/2018
1	Severe Acute Respiratory Syndrome 03/2014
1	Lung Diseases (Lung Disease) 12/2011
1	Weight Loss (Weight Reduction) 04/2010
1	Inflammation (Inflammations) 04/2010
1	Bronchiolitis 04/2010
1	Type 2 Diabetes Mellitus (MODY) 08/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2008
1	Heart Failure 08/2008
1	Pneumonia (Pneumonitis) 01/2007
1	Cataract (Cataracts) 07/2006

6	VaccinesIBA 01/2021 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2010
2	EpitopesIBA 01/2021 - 01/2019
1	LDL CholesterolIBA 03/2022
1	CholesterolIBA 01/2021
1	NanovaccinesIBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	CSL112IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	Peptide LibraryIBA 01/2019
1	Interferon Type IIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	pazopanib FDA Link 07/2015
1	Glycoproteins (Glycoprotein)IBA 03/2014
1	Biological ProductsIBA 02/2012
1	RNA (Ribonucleic Acid)IBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	MicroRNAs (MicroRNA)IBA 01/2011
1	NucleotidesIBA 01/2011
1	Long Noncoding RNAIBA 10/2010
1	InterferonsIBA 10/2010
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 10/2010
1	Interferon Receptors (Interferon Receptor)IBA 04/2010
1	Interferon LambdaIBA 04/2010
1	Rosiglitazone (Avandia)FDA Link 08/2008
1	Viral AntigensIBA 01/2007